It is still unknown why CPSF4 was overexpressed in lung cancer cells; however, based on the findings in the present study, we believe that CPSF4 may be a potential diagnostic and/or therapeutic target in lung adenocarcinomas. This evidence concerns the gene CPSF4 and lung carcinoma.